Overview

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

Status:
Completed

Trial end date:
2012-11-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of entinostat in combination with exemestane in the treatment of advanced breast cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Syndax Pharmaceuticals

Treatments:

Entinostat
Exemestane